Trends in cancerOct 10, 2025

RNA vaccines for cancer: changing immune treatment methods

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗

Updated Jan 7, 2026

Abstract

RNA-based vaccines are being explored as a promising approach in cancer immunotherapy.

Cancer vaccines may stimulate strong immune responses against tumors by targeting specific antigens.
RNA vaccines have gained attention due to their successful application during the COVID-19 pandemic.
Recent clinical applications of RNA vaccines in cancer treatment are summarized, indicating their potential use.
Strategies to enhance the efficacy and safety of RNA vaccines are highlighted.
Current challenges in RNA vaccine development are discussed, along with future directions for research.

Simplified

Cancer vaccines have emerged as a promising strategy in cancer immunotherapy, capable of eliciting robust antitumor immune responses by targeting tumor-associated antigens or tumor-specific antigens. Among the various vaccine platforms, RNA-based vaccines have garnered substantial attention, especially in light of the success of mRNA vaccines during the COVID-19 pandemic. This review outlines the fundamental characteristics of different RNA vaccine modalities, summarizes recent clinical applications in cancer treatment, and highlights strategies aimed at improving their efficacy and safety. Furthermore, we discuss the current challenges facing RNA vaccine development and offer perspectives on future directions in this rapidly advancing field.

Full Text

Full text is available at the source.

View Full Text ↗

RNA vaccines for cancer: changing immune treatment methods

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief